84% Key To Selling Non-Nicotine Vape Products, Such As Endexx Corpora-tion’s (OTC: EDXC) Hyla, Are Online And Chain Retail Volume From Giants Such As Amazon (NASDAQ: AMZN), Target (NYSE: TGT), Walgreens (NASDAQ: WBA) And CVS (NYSE: CVS)


84% key to selling non-nicotine Vape Products, such as Endexx Corporation’s (OTC: EDXC) Hyla, are online and chain retail volume from giants such as Amazon (NASDAQ: AMZN), Target (NYSE: TGT), Walgreens (NASDAQ: WBA) And CVS (NYSE: CVS). With Its newly acquired subsidiary Hyla’s Guarana-Based non-nicotine Vape Products, EDXC has the power of shelves in greater than 1,000 brick-and-mortar stores for product exposure and volume. Research from Grand View Research documents that 84% of vape sales are made at retail — so Hyla is well positioned for market share.

StockMarketPress is  a media company which is spotlighting the cannabis industry analyzing how growth in cannabis legalization by state in 2022 could impact companies and investors. Some of the stocks it recently reported on include Endexx Corporation (OTC: EDXC), Amazon (NASDAQ: AMZN), Target (NYSE: TGT), Walgreens (NASDAQ: WBA), CVS (NYSE: CVS), Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Supreme Cannabis Co. (OTC: SPRWF), The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), OrganiGram Holdings Inc. (NASDAQ: OGI), Canopy Growth Corp. (NASDAQ: CGC) CBD Unlimited, Inc. (OTC PINK: EDXC).

Grand View Research also finds that vaping appeals to a younger demographic. Initially, nicotine-based companies saw vaping as an alternative to traditional smoking. Now, non-nicotine vaping is growing. Its overwhelming presence both online and at chain retail such as Amazon (NASDAQ: AMZN), Target (NYSE: TGT), Walgreens (NASDAQ: WBA) and CVS (NYSE: CVS) only intensifies its success. EDXC recently acquired the Hyla non-nicotine brand as the future of vaping.  It seeks a larger market share in the  U.S. as well as a larger international distribution. Hyla is based on the Guarana plant.

Grand View Research finds that vaping is growing fast — at a 27.3% CAGR from 2021-2028

Hyla’s initial inventory of 140,000 devices were sold out within the initial months of its availability, Endexx says. It also says the device is CE approved and has UL global safety certification.

Endexx’s recent Form 8-K offers detail of the Hyla acquisition, and how it  strengthens its own balance sheet.

Source: Stock Market Press

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.


Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com https://twitter.com/PressStock

Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press